NOBELPHARMA

Serial Number 79272876
Registration 6015978
706

Registration Progress

Application Filed
Sep 13, 2019
Under Examination
Approved for Publication
Dec 18, 2019
Published for Opposition
Jan 7, 2020
Registered
Mar 24, 2020

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2020-03-24)
Due: Mar 24, 2026 239 days

Trademark Image

NOBELPHARMA

Basic Information

Serial Number
79272876
Registration Number
6015978
Filing Date
September 13, 2019
Registration Date
March 24, 2020
Published for Opposition
January 7, 2020
Drawing Code
3

Status Summary

Current Status
Active
Status Code
706
Status Date
Jul 15, 2025
Registration
Registered
Classes
005

Rights Holder

Nobelpharma Co., Ltd.

03
Address
NMF Kayabacho Bldg.,
1-17-24, Shinkawa, Chuo-ku
Tokyo 104-0033
JP

Ownership History

Nobelpharma Co., Ltd.

Original Applicant
03
JP

Nobelpharma Co., Ltd.

Owner at Publication
03
JP

Nobelpharma Co., Ltd.

Original Registrant
03
Tokyo JP

Legal Representation

Attorney
Sandra Epp Ryan

USPTO Deadlines

Next Deadline
239 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-03-24)
Due Date
March 24, 2026
Grace Period Ends
September 24, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

26 events
Date Code Type Description Documents
Jul 15, 2025 NA71 E NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED Loading...
Jul 15, 2025 71AG O REGISTERED-SEC.71 ACCEPTED Loading...
Jul 15, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Apr 17, 2025 ES71 I TEAS SECTION 71 RECEIVED Loading...
Mar 24, 2025 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Loading...
Jan 7, 2023 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Dec 24, 2021 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Dec 23, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Dec 23, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 23, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Dec 23, 2021 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Dec 23, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 23, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
May 22, 2020 GPNX P NOTIFICATION PROCESSED BY IB Loading...
May 7, 2020 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
May 7, 2020 FIMP P FINAL DISPOSITION PROCESSED Loading...
Apr 23, 2020 GPAR P GRANT OF PROTECTION CREATED, TO BE SENT TO IB Loading...
Mar 24, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 7, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 18, 2019 NPUB O NOTICE OF PUBLICATION Loading...
Dec 7, 2019 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Dec 4, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 3, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 3, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 2, 2019 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Nov 28, 2019 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
[ Pharmaceutical preparations for treating tympanic membrane perforation and ear canal soft tissue defect; ] pharmaceutical preparations for treating skin disorders [ ; vaccines; vaccines for treating malaria; pharmaceutical preparations for dysmenorrhea; pharmaceutical preparations for hypozincemia; pharmaceutical preparations for tympanic perforation; pharmaceutical preparations for sleep disorders; pharmaceutical preparations for pulmonary alveolar proteinosis; pharmaceutical preparations for distal myopathy; pharmaceutical preparations for CMV infection; pharmaceutical preparations for lymphatic disorder; pharmaceutical preparations for fibrodysplasia ossificans progressive; pharmaceutical preparations for Pendred syndrome ]

Additional Information

Color Claim
The color(s) blue, white and black is/are claimed as a feature of the mark.
Other
The white word "Nobel" is written in the blue square and the word "pharma" is written in black; in addition, an under line is drawn in black below the blue square.
Pseudo Mark
NOBEL PHARMA

Classification

International Classes
005